Janus Henderson Global Life Sciences Fund Class I (JFNIX) - Health fund with $6.03 Billion in assets. The fund allocates 37.82% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Eli Lilly Co. COM NPV at 8.84% of total assets. This is followed by UnitedHealth Group Inc. COM USD0.01 (3.13%) and Novo Nordisk A/S SER'B'DKK0.1 (3.65%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Eli Lilly Co. COM NPV | 8.84% | - | - |
| UnitedHealth Group Inc. COM USD0.01 | 3.13% | - | - |
| Novo Nordisk A/S SER'B'DKK0.1 | 3.65% | - | - |
| AstraZeneca PLC ORD USD0.25 | 4.59% | - | - |
| AbbVie Inc. COM USD0.01 | 4.05% | - | - |
| Merck Co., Inc COM USD0.50 | 3.28% | - | - |
| Amgen Inc. COM USD0.0001 | 2.87% | - | - |
| Sanofi EUR2 | 2.72% | - | - |
| Boston Scientific Corporation COM USD0.01 | 2.34% | - | - |
| Vertex Pharmaceuticals Incorporated COM USD0.01 | 2.35% | - | - |
| Johnson Johnson COM USD1.00 | 7.29% | - | - |
| Abbott Laboratories COM NPV | 2.40% | - | - |
| Argenx SE SPON ADR EACH REP 1 ORD SHS | 2.40% | - | - |
| Sanofi SA EUR2 | 2.69% | - | - |
| Novartis AG ADR-REP 1 CHF0.5 (REGD) | 2.86% | - | - |
| Praxis Precision Medicines Inc COM NEW | 2.45% | - | - |
| Thermo Fisher Scientific Inc COM USD1 | 2.51% | - | - |
| Eli Lilly Co. | 9.41% | - | - |
| Johnson Johnson | 7.09% | - | - |
| AbbVie, Inc. | 4.67% | - | - |
| UnitedHealth Group, Inc. | 4.54% | - | - |
| AstraZeneca plc | 3.93% | - | - |
| Revolution Medicines, Inc. | 3.02% | - | - |
| Argenx SE | 2.63% | - | - |
| Novartis AG | 2.56% | - | - |
| Thermo Fisher Scientific, Inc. | 2.33% | - | - |
| Praxis Precision Medicines, Inc. | 2.19% | - | - |